Results 81 to 90 of about 583,519 (287)

A Rare Case of Deep Vein Thrombosis: Paget-Schroetter Syndrome

Trends in Surgical Sciences
Paget-Schroetter syndrome is a rare form of upper extremity deep vein thrombosis (DVT), accounting for approximately 0.5%–1% of all DVT cases, and typically caused by repetitive upper extremity activities.
Mert Çelik
doaj   +1 more source

Vena cava anomalies in thoracic surgery [PDF]

, 2018
Background: Vena cava anomalies are a rare group of anatomical variations due to an incorrect development of the superior or inferior vena cava during fetal life.
Anile, Marco, Anzidei, Michele, Bassi, Massimiliano, Diso, Daniele, Mantovani, Sara, Pagini, Andreina, Poggi, Camilla, Venuta, Federico   +7 more
core   +1 more source

Dynamic blood dose estimates in radiotherapy and correlations with adverse clinical outcomes in brain, head‐and‐neck, and lung cancer patients

Journal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Background In cancer radiotherapy, radiation‐induced lymphopenia (RIL) has been reported to be correlated with adverse clinical outcomes such as reduced locoregional control (LRC), distant‐metastasis‐free survival (DMFS), and overall survival (OS) in various treatment sites.
Sebastian Tattenberg, Jungwook Shin, Cornelia Hoehr, Xuanfeng Ding, Rohan L. Deraniyagala, Wonmo Sung   +5 more
wiley   +1 more source

Safety of a Totally Implantable Central Venous Port System with Percutaneous Subclavian Vein Access

The Korean journal of thoracic and cardiovascular surgery, 2013
Background The role of totally implantable central venous port (TICVP) system is increasing. Implantation performed by radiologist with ultrasound-guided access of vein and fluoroscope-guided positioning of catheter is widely accepted nowadays.
D. Keum, Jae-Bum Kim, M. Chae
semanticscholar   +1 more source

Internal Jugular and Subclavian Vein Thrombosis in a Post-liver Transplant Patient [PDF]

, 2020
Deema Algoblan, Luluwah AlAitah, Abdullah M. Alotaibi   +2 more
openalex   +1 more source

Stable Atrial Sensing on Long-Term Follow Up of VDD Pacemakers [PDF]

, 2006
Background: The hemodynamic advantages of maintaining AV synchrony through AV synchronous pacing are widely known as compared to single chamber pacing.
Aithal, Jairam, Kerkar, Prafulla, Narula, Dhiraj, Shah, Ashok   +3 more
core   +2 more sources

Intentional Stent Fracture to Accommodate Growth After Coarctation Stenting in an 860‐g Neonate

Catheterization and Cardiovascular Interventions, Volume 107, Issue 1, Page 34-37, January 1, 2026.
ABSTRACT Background Congenital aortic coarctation in neonates and children can be managed with transcatheter stent implantation, but this approach raises the issue of how to accommodate the fixed stent structure within the growing vessel. Case Summary A 15‐month‐old boy, born prematurely with critical aortic coarctation, was treated at 1 week of age ...
Magdalena Cuman, Gernot Buheitel, Peter Ewert, Stanimir Georgiev   +3 more
wiley   +1 more source

Percutaneous subclavian artery stent-graft placement following failed ultrasound guided subclavian venous access

BMC Medical Imaging, 2006
Background Ultrasound guidance for central and peripheral venous access has been proven to improve success rates and reduce complications of venous cannulation.
Szkup Peter, Stoneham Grant, Burbridge Brent   +2 more
doaj   +1 more source

Ipsilateral jugular to distal subclavian vein transposition to relieve central venous hypertension in rescue vascular access surgery: a surgical report of 3 cases.

Annals of Thoracic and Cardiovascular Surgery, 2013
Central venous thrombosis may often arise following central venous cannulation for temporary haemodialysis access. Venous thrombosis may be clinically asymptomatic due to the presence of collateral circulation.
I. Acri, A. Carmignani, G. Vazzana, M. Massara, E. Acri, S. Lentini, F. Spinelli   +6 more
semanticscholar   +1 more source

Burosumab in Unidentifiable Tumor‐Induced Osteomalacia

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Tumor‐induced osteomalacia (TIO) can be challenging due to underlying tumors being either unresectable or unidentifiable. Burosumab, an anti‐FGF23 monoclonal antibody, has been proven to be effective in treating TIO but is currently not subsidized for this indication in Australia.
Yi Shan Der, Santosh Chaubey, Anna Mclean, Yasmin Trinh, Shelley Pember, Ashim Sinha   +5 more
wiley   +1 more source